← Back to company shares
IR
Ironclad Ventures
IRVE · BiotechnologyApplied biotechnology research aimed at treating chronic and rare conditions. Backed by Ironclad Ventures's operating track record in the biotechnology space.
Price / Share
$272.87
Shares Sold
253,943 / 750,000
Shares Remaining
496,057
34% subscribed
Log in to purchase shares